| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $373.3M | -14.6% |
| SG&A Expense | $62.8M | -52.0% |
| Operating Income | -$436.1M | +23.2% |
| Pre-tax Income | -$409.6M | +28.1% |
| Income Tax | -$1.4M | -415.8% |
| Net Income | -$408.2M | +28.4% |
| EPS (Basic) | -$5.73 | +55.1% |
| EPS (Diluted) | -$5.73 | +55.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $248.4M | +21.2% |
| Short-term Investments | $133.4M | -48.8% |
| Current Assets | $442.4M | -24.6% |
| Total Assets | $513.2M | -22.5% |
| Current Liabilities | $55.4M | -38.4% |
| Total Liabilities | $85.2M | -30.7% |
| Stockholders' Equity | $428.0M | -20.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$331.7M | -11.4% |
| Capital Expenditures | $3.0M | -49.8% |
| Investing Cash Flow | $129.8M | +142.6% |
| Financing Cash Flow | $211.9M | -72.4% |
| Free Cash Flow | -$334.8M | -10.2% |